Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Beyond Air Inc (XAIR)

Beyond Air Inc (XAIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Beyond Air Inc 900 STEWART AVENUE SUITE 301 GARDEN CITY NY 11530 USA

www.ait-pharm.com P: 516-665-8200

Description:

Beyond Air Inc. is a clinical-stage medical device and biopharmaceutical company. It is engaged in developing a Nitric Oxide Generator and Delivery System. The company's principal product is AirNOvent which is in clinical stage. Beyond Air Inc., formerly known as AIT Therapeutics Inc., is based in Garden City, New York.

Key Statistics

Overview:

Market Capitalization, $K 29,198
Enterprise Value, $K 33,108
Shares Outstanding, K 45,901
Annual Sales, $ 1,160 K
Annual Net Income, $ -60,240 K
Last Quarter Sales, $ 470 K
Last Quarter Net Income, $ -13,710 K
EBIT, $ -63,010 K
EBITDA, $ -59,510 K
60-Month Beta -0.09
% of Insider Shareholders 19.00%
% of Institutional Shareholders 31.50%
Float, K 37,180
% Float 81.00%
Short Volume Ratio 0.35

Growth:

1-Year Return -85.63%
3-Year Return -90.22%
5-Year Return -88.32%
5-Year Revenue Growth -84.97%
5-Year Earnings Growth -116.67%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.36 on 06/24/24
Next Earnings Date 08/08/24
Earnings Per Share ttm -1.82
EPS Growth vs. Prev Qtr 28.00%
EPS Growth vs. Prev Year 46.27%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

XAIR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -203.12%
Return-on-Assets % -100.44%
Profit Margin % -5,193.10%
Debt/Equity 0.57
Price/Sales 21.28
Price/Cash Flow N/A
Price/Book 0.71
Book Value/Share 0.75
Interest Coverage -21.10
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar